×
More Charts Below
Precipio Income from Continuous Operations 2010-2024 | PRPO
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Recent Trends
Precipio income from continuous operations from 2010 to 2024. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
Related Stocks
Company Name
Market
Cap
Veeva Systems (VEEV)
$35.1B
Tempus AI (TEM)
$7B
Hims & Hers Health (HIMS)
$6B
Inspire Medical Systems (INSP)
$4.5B
IRhythm Technologies (IRTC)
$3.2B
Privia Health (PRVA)
$2.9B
Schrodinger (SDGR)
$1.9B
Clover Health Investments (CLOV)
$1.8B
Enovis (ENOV)
$1.8B
Omnicell (OMCL)
$1.4B
Phreesia (PHR)
$1.4B
Azenta (AZTA)
$1.2B
10x Genomics (TXG)
$918M
Butterfly Network (BFLY)
$568M
Fulgent Genetics (FLGT)
$551M
Talkspace (TALK)
$450M
Veradigm (MDRX)
$449M
Standard BioTools (LAB)
$440M
TruBridge (TBRG)
$363M
Claritev (CTEV)
$325M
Health Catalyst (HCAT)
$270M
Nyxoah SA (NYXH)
$206M
SOPHiA GENETICS SA (SOPH)
$189M
Pulmonx (LUNG)
$182M
American Well (AMWL)
$109M
EUDA Health Holdings (EUDA)
$100M
Retrieve Medical Holdings (RMHI)
$82M
MDxHealth SA (MDXH)
$76M
P3 Health Partners (PIII)
$66M
111 (YI)
$64M